SWTX:NSD-SpringWorks Therapeutics Inc (USD)

COMMON STOCK | Biotechnology |

Last Closing

USD 36.35

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.60M

Analyst Target

USD 54.40
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-29 )

Largest Industry Peers for Biotechnology

Symbol Name Price(Change) Market Cap
VRTX Vertex Pharmaceuticals Inc

N/A

USD 120.60B
REGN Regeneron Pharmaceuticals Inc

N/A

USD 84.94B
ARGX argenx NV ADR

N/A

USD 36.54B
ALNY Alnylam Pharmaceuticals Inc

N/A

USD 31.66B
BGNE BeiGene Ltd

N/A

USD 20.24B
UTHR United Therapeutics Corporatio..

N/A

USD 16.18B
MRNA Moderna Inc

N/A

USD 16.10B
RPRX Royalty Pharma Plc

N/A

USD 15.05B
INCY Incyte Corporation

N/A

USD 13.52B
SMMT Summit Therapeutics PLC

N/A

USD 13.43B

ETFs Containing SWTX

HFIN:CA Hamilton Enhanced Canadia.. 10.20 % 0.00 %

N/A

CAD 0.20B
HLIF:CA Harvest Canadian Equity I.. 3.45 % 0.00 %

N/A

CAD 0.12B
XMV:CA iShares MSCI Canada Minim.. 2.95 % 0.33 %

N/A

CAD 0.25B
TLV:CA Invesco S&P/TSX Composite.. 2.35 % 0.34 %

N/A

CAD 0.07B
XMD:CA iShares S&P/TSX Completio.. 1.94 % 0.61 %

N/A

CAD 0.23B
CNCR Loncar Cancer Immunothera.. 1.68 % 0.79 %

N/A

USD 0.01B
CEW:CA iShares Equal Weight Banc.. 0.00 % 0.60 %

N/A

CAD 0.24B
DXM:CA 0.00 % 0.67 %

N/A

N/A
FIE:CA iShares Canadian Financia.. 0.00 % 0.97 %

N/A

CAD 1.09B
FLI:CA CI U.S. & Canada Lifeco C.. 0.00 % 0.92 %

N/A

CAD 0.09B
HEF:CA 0.00 % 0.83 %

N/A

N/A
HPR:CA Global X Active Preferred.. 0.00 % 0.63 %

N/A

CAD 1.04B
PR:CA Lysander-Slater Preferred.. 0.00 % 1.03 %

N/A

CAD 0.08B
RODM Hartford Multifactor Deve.. 0.00 % 0.31 %

N/A

N/A
BANK:CA Evolve Canadian Banks and.. 0.00 % 0.39 %

N/A

CAD 0.33B
BNC:CA Purpose Canadian Financia.. 0.00 % 0.68 %

N/A

N/A
TQCD:CA TD Q Canadian Dividend ET.. 0.00 % 0.00 %

N/A

CAD 0.38B
TPIF Timothy Plan Internationa.. 0.00 % 0.00 %

N/A

USD 0.11B
FICS First Trust International.. 0.00 % 0.00 %

N/A

USD 0.16B

Market Performance

  Market Performance vs. Industry/Classification (Biotechnology) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.41% 66% D+ 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.41% 66% D+ 46% F
Trailing 12 Months  
Capital Gain -0.41% 66% D+ 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.41% 66% D+ 46% F
Trailing 5 Years  
Capital Gain -5.56% 74% C 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.56% 74% C 41% F
Average Annual (5 Year Horizon)  
Capital Gain 17.76% 64% D 71% C-
Dividend Return 17.76% 64% D 70% C-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 65.22% 54% F 30% F
Risk Adjusted Return 27.22% 81% B- 59% D-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector